Assessing tumor cytoarchitecture using multiecho DSC-MRI derived measures of the transverse relaxivity at tracer equilibrium (TRATE)

Magnetic Resonance in Medicine

Volumn 74, Issue 3, 2015, Pages 772-784

  Semmineh, Natenael B ^a   Xu, Junzhong ^a   Skinner, Jack T ^a   Xie, Jingping ^a   Li, Hua ^a   Ayers, Gregory ^b   Quarles, C Chad ^a,b,c,d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cellular structures; contrast agent equilibrium; contrast agent leakage; dynamic susceptibility contrast; transverse relaxation; vascular structures

Indexed keywords

BRAIN; MAGNETIC SUSCEPTIBILITY; SURFACE DIFFUSION; TRACERS;

CELLULAR STRUCTURE; CONTRAST AGENT; DYNAMIC SUSCEPTIBILITY CONTRAST; TRANSVERSE RELAXATION; VASCULAR STRUCTURES;

TUMORS;

GADOLINIUM PENTETATE; CONTRAST MEDIUM;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CELL DENSITY; CELL SIZE; CLINICAL ARTICLE; CYTOARCHITECTURE; DYNAMIC SUSCEPTIBILITY CONTRAST MAGNETIC RESONANCE IMAGING; FEMALE; HISTOLOGY; HUMAN; IN VITRO STUDY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; RADIOACTIVITY; RADIOLOGICAL PARAMETERS; RAT; SENSITIVITY ANALYSIS; SIMULATION; SPATIAL ANALYSIS; TRANSVERSE RELAXIVITY AT TRACER EQUILIBRIUM; ANIMAL; BIOLOGICAL MODEL; BRAIN; COMPUTER SIMULATION; CYTOLOGY; FISCHER 344 RAT; MIDDLE AGED; PATHOLOGY; PROCEDURES; WISTAR RAT;

AGED; ANIMALS; BRAIN; BRAIN NEOPLASMS; COMPUTER SIMULATION; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RATS; RATS, INBRED F344; RATS, WISTAR;

EID: 84939565772     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.25435     Document Type: Article

References (55)

1. Aronen HJ, Gazit IE, Louis DN, et al., Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 191: 41-51.
2. Aronen HJ, Pardo FS, Kennedy DN, Belliveau JW, Packard SD, Hsu DW, Hochberg FH, Fischman AJ, Rosen BR,. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 2000; 6: 2189-2200.
3. Batchelor TT, Sorensen AG, di Tomaso E, et al., AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 2007; 11: 83-95.
4. Bruening R, Kwong KK, Vevea MJ, Hochberg FH, Cher L, Harsh GRt, Niemi PT, Weisskoff RM, Rosen BR,. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting. AJNR Am J Neuroradiol 1996; 17: 831-840.
5. Donahue KM, Krouwer HG, Rand SD, Pathak AP, Marszalkowski CS, Censky SC, Prost RW,. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 2000; 43: 845-853.
6. Maeda M, Itoh S, Kimura H, Iwasaki T, Hayashi N, Yamamoto K, Ishii Y, Kubota T,. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology 1993; 189: 233-238.
7. Sugahara T, Korogi Y, Kochi M, Ushio Y, Takahashi M,. Perfusion-sensitive MR imaging of gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques. AJNR Am J Neuroradiol 2001; 22: 1306-1315.
8. Lemasson B, Serduc R, Maisin C, Bouchet A, Coquery N, Robert P, Le Duc G, Tropres I, Remy C, Barbier EL,. Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of low-molecular-weight and macromolecular MR contrast media. Radiology 2010; 257: 342-352.
9. Siegal T, Rubinstein R, Tzuk-Shina T, Gomori JM,. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors. J Neurosurg 1997; 86: 22-27.
10. Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T, Liang L, Ushio Y, Takahashi M,. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000; 21: 901-909.
11. Kamoun WS, Ley CD, Farrar CT, et al., Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice. J Clin Oncol 2009; 27: 2542-2552.
12. Sorensen AG, Emblem KE, Polaskova P, et al., Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion. Cancer Res 2012; 72: 402-407.
13. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM,. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995; 34: 555-566.
14. Quarles CC, Gochberg DF, Gore JC, Yankeelov TE,. A theoretical framework to model DSC-MRI data acquired in the presence of contrast agent extravasation. Phys Med Biol 2009; 54: 5749-5766.
15. Sourbron S, Heilmann M, Biffar A, Walczak C, Vautier J, Volk A, Peller M,. Bolus-tracking MRI with a simultaneous T1- and T2∗-measurement. Magn Reson Med 2009; 62: 672-681.
16. Sourbron S, Heilmann M, Walczak C, Vautier J, Schad LR, Volk A,. T2∗-relaxivity contrast imaging: first results. Magn Reson Med 2013; 69: 1430-1437.
17. Quarles CC, Ward BD, Schmainda KM,. Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation. Magn Reson Med 2005; 53: 1307-1316.
18. Bjornerud A, Sorensen AG, Mouridsen K, Emblem KE,. T1- and T2∗-dominant extravasation correction in DSC-MRI: part I-theoretical considerations and implications for assessment of tumor hemodynamic properties. J Cereb Blood Flow Metab 2011; 31: 2041-2053.
19. Boxerman JL, Schmainda KM, Weisskoff RM,. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006; 27: 859-867.
20. Emblem KE, Bjornerud A, Mouridsen K, Borra RJ, Batchelor TT, Jain RK, Sorensen AG,. T(1)- and T(2)(∗)-dominant extravasation correction in DSC-MRI: part II-predicting patient outcome after a single dose of cediranib in recurrent glioblastoma patients. J Cereb Blood Flow Metab 2011; 31: 2054-2064.
21. Paulson ES, Schmainda KM,. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 2008; 249: 601-613.
22. Schmiedeskamp H, Andre JB, Straka M, Christen T, Nagpal S, Recht L, Thomas RP, Zaharchuk G, Bammer R,. Simultaneous perfusion and permeability measurements using combined spin- and gradient-echo MRI. J Cereb Blood Flow Metab 2013; 33: 732-743.
23. Kim EJ, Kim DH, Lee SH, Huh YM, Song HT, Suh JS,. Simultaneous acquisition of perfusion and permeability from corrected relaxation rates with dynamic susceptibility contrast dual gradient echo. Magn Reson Imaging 2004; 22: 307-314.
24. Quarles CC, Gore JC, Xu L, Yankeelov TE,. Comparison of dual-echo DSC-MRI- and DCE-MRI-derived contrast agent kinetic parameters. Magnetic Reson Imaging 2012; 30: 944-953.
25. Sourbron S, Ingrisch M, Siefert A, Reiser M, Herrmann K,. Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI. Magn Reson Med 2009; 62: 205-217.
26. Vonken EP, van Osch MJ, Bakker CJ, Viergever MA,. Simultaneous quantitative cerebral perfusion and Gd-DTPA extravasation measurement with dual-echo dynamic susceptibility contrast MRI. Magn Reson Med 2000; 43: 820-827.
27. Mangla R, Kolar B, Zhu T, Zhong J, Almast J, Ekholm S,. Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain. AJNR Am J Neuroradiol 2011; 32: 1004-1010.
28. Pannetier NA, Debacker CS, Mauconduit F, Christen T, Barbier EL,. A simulation tool for dynamic contrast enhanced MRI. PloS One 2013; 8: e57636.
29. Semmineh NB, Xu J, Boxerman JL, Delaney GW, Cleary PW, Gore JC, Quarles CC,. An efficient computational approach to characterize DSC-MRI signals arising from three-dimensional heterogeneous tissue structures. PloS One 2014; 9: e84764.
30. Rybaczuk M, Kedzia A, Paradowski L,. Fractal characteristics of brain vessel microangioarchitecture during the fetal period. Med Sci Monit 2002; 8: MT145-152.
31. Schreiner W, Neumann F, Neumann M, End A, Muller MR,. Structural quantification and bifurcation symmetry in arterial tree models generated by constrained constructive optimization. J Theor Biol 1996; 180: 161-174.
32. Delaney GW, Cleary PW,. The packing properties of superellipsoids. Europhys Lett 2010; 89: 34002.
33. Le Bihan D,. [Diffusion, perfusion and functional magnetic resonance imaging]. J Mal Vasc 1995; 20: 203-214.
34. Weisskoff RM, Kiihne S,. MRI susceptometry: image-based measurement of absolute susceptibility of MR contrast agents and human blood. Magn Reson Med 1992; 24: 375-383.
35. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ,. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005; 40: 715-724.
36. Barbier EL, den Boer JA, Peters AR, Rozeboom AR, Sau J, Bonmartin A,. A model of the dual effect of gadopentetate dimeglumine on dynamic brain MR images. J Magn Reson Imaging 1999; 10: 242-253.
37. Yankeelov TE, Luci JJ, Lepage M, Li R, Debusk L, Lin PC, Price RR, Gore JC,. Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. Magn Reson Imaging 2005; 23: 519-529.
38. Wu O, Ostergaard L, Weisskoff RM, Benner T, Rosen BR, Sorensen AG,. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 2003; 50: 164-174.
39. Brix G, Bahner ML, Hoffmann U, Horvath A, Schreiber W,. Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT-initial experience. Radiology 1999; 210: 269-276.
40. Jain RK,. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987; 47: 3039-3051.
41. Gillis P, Peto S, Moiny F, Mispelter J, Cuenod CA,. Proton transverse nuclear magnetic relaxation in oxidized blood: a numerical approach. Magn Reson Med 1995; 33: 93-100.
42. Kiselev VG, Novikov DS,. Transverse NMR relaxation as a probe of mesoscopic structure. Phys Rev Lett 2002; 89: 278101.
43. Thulborn KR, Waterton JC, Matthews PM, Radda GK,. Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. Biochim Biophys Acta 1982; 714: 265-270.
44. Hazlewood CF, Chang DC, Nichols BL, Woessner DE,. Nuclear magnetic resonance transverse relaxation times of water protons in skeletal muscle. Biophys J 1974; 14: 583-606.
45. Stables LA, Kennan RP, Gore JC,. Asymmetric spin-echo imaging of magnetically inhomogeneous systems: theory, experiment, and numerical studies. Magn Reson Med 1998; 40: 432-442.
46. Hosokawa M, Kenmotsu H, Koh Y, et al., Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. PloS One 2013; 8: e67466.
47. van Osch MJ, Vonken EJ, Viergever MA, van der Grond J, Bakker CJ,. Measuring the arterial input function with gradient echo sequences. Magn Reson Med 2003; 49: 1067-1076.
48. Anderson AW, Xie J, Pizzonia J, Bronen RA, Spencer DD, Gore JC,. Effects of cell volume fraction changes on apparent diffusion in human cells. Magn Reson Imaging 2000; 18: 689-695.
49. Kennan RP, Zhong J, Gore JC,. Intravascular susceptibility contrast mechanisms in tissues. Magn Reson Med 1994; 31: 9-21.
50. Pathak AP, Rand SD, Schmainda KM,. The effect of brain tumor angiogenesis on the in vivo relationship between the gradient-echo relaxation rate change (DeltaR2∗) and contrast agent (MION) dose. J Magn Reson Imaging 2003; 18: 397-403.
51. Weisskoff RM, Zuo CS, Boxerman JL, Rosen BR,. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med 1994; 31: 601-610.
52. Yablonskiy DA, Haacke EM,. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994; 32: 749-763.
53. Boxerman JL, Paulson ES, Prah MA, Schmainda KM,. The effect of pulse sequence parameters and contrast agent dose on percentage signal recovery in DSC-MRI: implications for clinical applications. AJNR Am J Neuroradiol 2013; 34: 1364-1369.
54. Skinner JT, Yankeelov TE, Peterson TE, Does MD,. Comparison of dynamic contrast-enhanced MRI and quantitative SPECT in a rat glioma model. Contrast Media Mol Imaging 2012; 7: 494-500.
55. Moffat BA, Chenevert TL, Lawrence TS, et al., Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 2005; 102: 5524-5529.